These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 15522979)
1. Long-acting injectable risperidone. Ehret MJ; Fuller MA Ann Pharmacother; 2004 Dec; 38(12):2122-7. PubMed ID: 15522979 [TBL] [Abstract][Full Text] [Related]
2. Clinical review of a long-acting, injectable formulation of risperidone. Knox ED; Stimmel GL Clin Ther; 2004 Dec; 26(12):1994-2002. PubMed ID: 15823763 [TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics. Lindenmayer JP; Eerdekens E; Berry SA; Eerdekens M J Clin Psychiatry; 2004 Aug; 65(8):1084-9. PubMed ID: 15323593 [TBL] [Abstract][Full Text] [Related]
4. Clinical experience with the long-acting injectable formulation of the atypical antipsychotic, risperidone. Martin SD; Libretto SE; Pratt DJ; Brewin JS; Huq ZU; Saleh BT Curr Med Res Opin; 2003; 19(4):298-305. PubMed ID: 12841922 [TBL] [Abstract][Full Text] [Related]
5. [Long-acting injectable risperidone: naturalistic study in three hospitals in Aquitaine]. Raignoux C; Dusouchet T; Bret P; Queuille E; Biscay ML; Caron J; Bret MC Encephale; 2007 Dec; 33(6):973-81. PubMed ID: 18789790 [TBL] [Abstract][Full Text] [Related]
6. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies. Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596 [TBL] [Abstract][Full Text] [Related]
8. [The first long-acting atypical antipsychotic: new milestone in the treatment of schizophrenia]. Faludi G Neuropsychopharmacol Hung; 2005 Mar; 7(1):22-7. PubMed ID: 16167464 [TBL] [Abstract][Full Text] [Related]
9. Clinical experience and management considerations with long-acting risperidone. Parellada E Curr Med Res Opin; 2006 Feb; 22(2):241-55. PubMed ID: 16466596 [TBL] [Abstract][Full Text] [Related]
10. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder. Houthoofd SA; Morrens M; Sabbe BG Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365 [TBL] [Abstract][Full Text] [Related]
11. A randomized controlled trial of long-acting injectable risperidone vs continuation on oral atypical antipsychotics for first-episode schizophrenia patients: initial adherence outcome. Weiden PJ; Schooler NR; Weedon JC; Elmouchtari A; Sunakawa A; Goldfinger SM J Clin Psychiatry; 2009 Oct; 70(10):1397-406. PubMed ID: 19906343 [TBL] [Abstract][Full Text] [Related]
12. Strategies for improving compliance in treatment of schizophrenia by using a long-acting formulation of an antipsychotic: clinical studies. Kane JM J Clin Psychiatry; 2003; 64 Suppl 16():34-40. PubMed ID: 14680417 [TBL] [Abstract][Full Text] [Related]
13. A review of compliance, depot intramuscular antipsychotics and the new long-acting injectable atypical antipsychotic risperidone in schizophrenia. Bhanji NH; Chouinard G; Margolese HC Eur Neuropsychopharmacol; 2004 Mar; 14(2):87-92. PubMed ID: 15013023 [TBL] [Abstract][Full Text] [Related]
14. Risperidone in acute and long-term therapy of schizophrenia--a clinical profile. Pajonk FG Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):15-23. PubMed ID: 14687852 [TBL] [Abstract][Full Text] [Related]
15. Remission in patients with first-episode schizophrenia receiving assured antipsychotic medication: a study with risperidone long-acting injection. Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J Int Clin Psychopharmacol; 2008 Nov; 23(6):325-31. PubMed ID: 18854720 [TBL] [Abstract][Full Text] [Related]
17. Paliperidone extended-release tablets for the acute and maintenance treatment of schizophrenia. Fowler JA; Bettinger TL; Argo TR Clin Ther; 2008 Feb; 30(2):231-48. PubMed ID: 18343262 [TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy and safety of long-acting risperidone and risperidone oral tablets. Chue P; Eerdekens M; Augustyns I; Lachaux B; Molcan P; Eriksson L; Pretorius H; David AS Eur Neuropsychopharmacol; 2005 Jan; 15(1):111-7. PubMed ID: 15572280 [TBL] [Abstract][Full Text] [Related]
19. Use of long-acting risperidone in psychiatric disorders: focus on efficacy, safety and cost-effectiveness. Keith S Expert Rev Neurother; 2009 Jan; 9(1):9-31. PubMed ID: 19102665 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of risperidone long-acting injectable in stable psychotic patients previously treated with oral risperidone. Schmauss M; Sacchetti E; Kahn JP; Medori R Int Clin Psychopharmacol; 2007 Mar; 22(2):85-92. PubMed ID: 17293708 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]